Clinical Trials Logo

Cardiovascular clinical trials

View clinical trials related to Cardiovascular.

Filter by:
  • Completed  
  • Page 1 ·  Next »

NCT ID: NCT04863040 Completed - Obesity Clinical Trials

The Impact of Activity Breaks on Cognitive Function, Adiposity and Fitness in Preschoolers

MOVI-HIIT
Start date: June 1, 2020
Phase: N/A
Study type: Interventional

Project which objective is a) to test the effectiveness, in preschool children, of an integrated physical activity intervention in the classroom based on intervallic training (MOVI-HIIT) on improving executive function, body composition, cardiorespiratory fitness and b) to evaluate teachers' perceptions of barriers and facilitating elements for the implementation and monitoring of MOVI-HIIT interventions in the classroom.

NCT ID: NCT04216238 Completed - Cardiovascular Clinical Trials

Association of Wearable Activity Monitors With Post-Operative Activity Level Among Cardiovascular Surgical Patients

Start date: August 13, 2019
Phase:
Study type: Observational

Early mobility in the post cardiovascular surgical patient can dramatically impact patient outcomes. Utilizing an innovative strategy, like a wearable activity monitor, can potentially provide: accurate data on post-operative mobility level; increased motivation and self-efficacy in the recovering patient; data to potentially drive post-operative mobility goal setting. Use of a wearable activity monitor will reduce time needed to return to pre-operative activity level in the cardiovascular surgical patient.

NCT ID: NCT04121416 Completed - Cardiovascular Clinical Trials

Comparison of Effects of Oxycodone and Sufentanil on Cardiovascular Stress Induced by Tracheal Intubation in the Patients With Coronary Heart Disease Undergoing Major Noncardiac Surgery

Start date: April 1, 2019
Phase: N/A
Study type: Interventional

To evaluate the effect of oxycodone and sufentanil in preventing cardiovascular responses to tracheal intubation in the patients with coronary heart disease (CHD).

NCT ID: NCT03236363 Completed - Obesity Clinical Trials

Effectiveness of MOVI Interventions on Adiposity, Cognition and Motor Competence: MOVI-da10!

MOVI-da10!
Start date: September 19, 2017
Phase: N/A
Study type: Interventional

Project which objective is to test the effectiveness of a classroom-based physical activity intervention (MOVI-da10!) on improving, body composition, cardio-respiratory fitness and executive function.

NCT ID: NCT03236337 Completed - Obesity Clinical Trials

Effectiveness of MOVI Interventions on Adiposity, Cognition and Subclinical Atherosclerosis: MOVI-daFit!

Start date: September 19, 2017
Phase: N/A
Study type: Interventional

Project which objective is to test the effectiveness of an extracurricular physical activity intervention based on high intensity interval training (MOVI-daFit!) on improving cardiorespiratory fitness (CRF), cardiometabolic risk, executive function, and academic performance.

NCT ID: NCT03203863 Completed - Children Clinical Trials

Metabolic Syndrome in Children and Adolescents

Start date: April 1, 2009
Phase: N/A
Study type: Observational

The purpose of this study was to cross-sectionally evaluate nutritional status and the metabolic syndrome in a sample of school-age children 10-15 years of age from 20 public schools in Santiago, Chile. In addition, the investigators retrospectively assessed the association of those variables with perinatal variables (birth weight, birth length, and gestational age at delivery).

NCT ID: NCT03170193 Completed - Cardiovascular Clinical Trials

AMG 529 First in Human Study

Start date: May 15, 2017
Phase: Phase 1
Study type: Interventional

A study to assess the safety and tolerability of AMG 529 following single, ascending doses administered subcutaneously (SC) or intravenously (IV) in healthy adults.

NCT ID: NCT01489696 Completed - Healthy Subjects Clinical Trials

A Study to Evaluate Cardiovascular Interactions Between Mirabegron and Tamsulosin

Start date: August 2010
Phase: Phase 1
Study type: Interventional

The study aims to compare blood pressure and pulse in male healthy subjects taking mirabegron and tamsulosin both alone and in combination.

NCT ID: NCT01304641 Completed - Dyslipidemia Clinical Trials

Cardiovascular Events Based On Statin Initiation In The Elderly

Start date: November 2009
Phase:
Study type: Observational

The purpose of this study is to compare rates and risk of primary cardiovascular events among elderly patients newly initiating therapy with atorvastatin or simvastatin. The specific objectives for this project are to: 1) examine the demographic and clinical characteristics of the elderly patients in whom atorvastatin or simvastatin was newly initiated; and 2) compare cardiovascular event rates in elderly patients in whom atorvastatin or simvastatin was newly initiated.

NCT ID: NCT01232309 Completed - Cardiovascular Clinical Trials

Effects of Chitin-Glucan on Oxidized Low-Density Lipoprotein (LDL)

Start date: August 2010
Phase: N/A
Study type: Interventional

Cardiovascular diseases (CVDs), especially atherosclerotic coronary heart disease and stroke, are the leading causes of death globally. Important risk factors for CVDs include elevated serum levels of total cholesterol, low-density lipoprotein(LDL)-cholesterol, triglycerides, and low high-density lipoprotein (HDL)-cholesterol. Elevated "oxidized" LDL, a pro-inflammatory villain, has also emerged as an important risk factor for the development of CVDs. There is a growing need to identify safe and effective nutritional interventions that offer a clinical benefit aimed at reducing one more of the risk factors for CVDs. Data from many studies in humans have shown various health benefits provided by dietary fiber intake, including an inverse association with the risk of developing cardiovascular disease. The primary purpose of this study is to determine whether daily consumption for 6 weeks of chitin-glucan, a fiber purified from a microorganism, is effective at reducing the amount of oxidized LDL in humans with borderline-to-high LDL-cholesterol. The effects of chitin-glucan on other cardiovascular risk factors will also be evaluated.